Literature DB >> 447869

Haematological features of angioimmunoblastic lymphadenopathy with dysproteinaemia.

R L Brearley, J Chapman, M H Cullen, M A Horton, A G Stansfeld, A H Waters.   

Abstract

A study of seven patients with AILD has confirmed previously reported cytological and immunological changes in the peripheral blood. In themselves these changes should not be considered as specific. Histological examination of the bone marrow may show more characteristic lesions which involve haemopoietic, lymphoid, and stromal cells. Three patients had bone marrow features similar to myelofibrosis, which are considered to be diagnostic of AILD.

Entities:  

Mesh：

Year:  1979        PMID： 447869      PMCID： PMC1145672          DOI： 10.1136/jcp.32.4.356

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  18 in total

1.  THE PRODUCTION OF EOSINOPHILIC DEPOSITS RESEMBLING FIBRINOID BY INJECTIONS OF LYMPH-NODE EXTRACTS.

Authors:  D A WILLOUGHBY; W G SPECTOR
Journal:  J Pathol Bacteriol       Date:  1964-10

2.  Antibody elution from red blood cells.

Authors:  H RUBIN
Journal:  J Clin Pathol       Date:  1963-01       Impact factor: 3.411

3.  Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically pathologically malignant lymphomas.

Authors:  S L SALTZSTEIN; L V ACKERMAN
Journal:  Cancer       Date:  1959 Jan-Feb       Impact factor: 6.860

4.  Angio-immunoblastic lymphadenopathy with dysproteinaemia.

Authors:  G Frizzera; E M Moran; H Rappaport
Journal:  Lancet       Date:  1974-06-01       Impact factor: 79.321

5.  Postvaccinial lymphadenitis. Hyperplasia of lymphoid tissue that simulates malignant lymphomas.

Authors:  R J Hartsock
Journal:  Cancer       Date:  1968-04       Impact factor: 6.860

6.  Angioimmunoblastic lymphadenopathy: an ultrastructural and immunologic study with review of the literature.

Authors:  R S Neiman; P Dervan; C Haudenschild; R Jaffe
Journal:  Cancer       Date:  1978-02       Impact factor: 6.860

7.  Hematologic aspects of systemic lupus erythematosus. Current concepts.

Authors:  D R Budman; A D Steinberg
Journal:  Ann Intern Med       Date:  1977-02       Impact factor: 25.391

8.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 10-1978.

Authors: 
Journal:  N Engl J Med       Date:  1978-03-16       Impact factor: 91.245

9.  Malignant lymphoma arising in angioimmunoblastic lymphadenopathy.

Authors:  B N Nathwani; H Rappaport; E M Moran; G A Pangalis; H Kim
Journal:  Cancer       Date:  1978-02       Impact factor: 6.860

10.  Blood and bone marrow findings in angioimmunoblastic lymphadenopathy.

Authors:  G A Pangalis; E M Moran; H Rappaport
Journal:  Blood       Date:  1978-01       Impact factor: 22.113
View more
  6 in total

1.  Uncommon late relapse of angioimmunoblastic T-cell lymphoma after 16-year remission period.

Authors:  Edit Páyer; Zsófia Miltényi; Zsófia Simon; Lajos Szabados; Katalin Hegyi; Gábor Méhes; Arpád Illés
Journal:  Pathol Oncol Res       Date:  2011-11-30       Impact factor: 3.201

2.  Emergence of anti-mitochondrial M2 antibody in patient with angioimmunoblastic T-cell lymphoma.

Authors:  Shun-Ichi Wakabayashi; Takefumi Kimura; Naoki Tanaka; Satoru Joshita; Kazuhito Kawata; Takeji Umemura; Yuki Hiroshima; Hiromitsu Mori; Hikaru Kobayashi; Shuichi Wada; Eiji Tanaka
Journal:  Clin J Gastroenterol       Date:  2018-02-10

3.  Angioimmunoblastic lymphadenopathy and hypercalcaemia.

Authors:  M J Sworn; R Buchanan; D A McGill
Journal:  J Clin Pathol       Date:  1979-10       Impact factor: 3.411

Review 4.  Bone biopsy in haematological disorders.

Authors:  R Burkhardt; B Frisch; R Bartl
Journal:  J Clin Pathol       Date:  1982-03       Impact factor: 3.411

5.  Rapidly fatal respiratory failure and angioimmunoblastic lymphadenopathy: possible contributions of immunoblastic leukaemia, chemotherapy, and multiple antibodies directed against mature blood cells.

Authors:  P M Trenchard; J A Whittaker; J Gough; H Parry
Journal:  J Clin Pathol       Date:  1981-05       Impact factor: 3.411

6.  Blood findings in lymphogranulomatosis X.

Authors:  R Zankowich; M R Parwaresch; K Lennert
Journal:  Blut       Date:  1984-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.